MONKEYPOX (MPOX)
Clinical trials for MONKEYPOX (MPOX) explained in plain language.
Never miss a new study
Get alerted when new MONKEYPOX (MPOX) trials appear
Sign up with your email to follow new studies for MONKEYPOX (MPOX), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New mpox vaccine trial launches in DRC: could it be a game changer?
⭐️ VACCINE ⭐️ Not yet recruitingThis Phase 2 study will test a new mpox vaccine called MVA-SIBP in 180 people aged 2 to 45 in Kinshasa, DRC. Participants will receive two doses of either a low or high dose of the new vaccine, or a licensed vaccine (MVA-BN) for comparison. The goal is to check safety and how wel…
Matched conditions: MONKEYPOX (MPOX)
Phase: PHASE2 • Sponsor: Shanghai Institute Of Biological Products • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:00 UTC
-
Mpox booster study aims to see how long protection lasts
Knowledge-focused Not yet recruitingThis observational study will follow 95 adults who receive a booster dose of the MVA-BN vaccine against mpox. Researchers will collect blood and other samples over two years to measure antibody and immune cell responses. The goal is to understand how long the booster's protection…
Matched conditions: MONKEYPOX (MPOX)
Sponsor: Institute of Tropical Medicine, Belgium • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC